The price of insulin has emerged as a big campaign topic during this year’s presidential election. For years, pharmacy ...

Lilly’s decision to reduce prices ... for pharmacy benefit managers and pharmacies increased. As a result, the study concluded that policymakers should “consider entities through the insulin ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

The vote authorized the retention of solicitor Matthew Gieg as counsel in regard to the rising cost of insulin, which has ...

When Novo Nordisk slashed the prices of its insulin products, pharmacy benefit managers blocked access to some consumers by excluding some forms of insulin from the lists of drugs consumers can ...

WASHINGTON, Oct 30 (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin ... as pharmacy benefit managers for high drug prices.

The 'big three' insulin producers Novo ... to set artificially inflated prices for their products. The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US ...

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...

(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...